Respiratory syncytial virus--a comprehensive review (Q38098094)

28 August 2017

1 reference

23 October 2022

Respiratory syncytial virus--a comprehensive review (English)

1 reference

28 August 2017

3

M Eric Gershwin

1 reference

28 August 2017

Andrea T Borchers

1

1 reference

28 August 2017

Christopher Chang

series ordinal

2

1 reference

28 August 2017

Laurel J Gershwin

series ordinal

4

1 reference

28 August 2017

1 December 2013

2 references

Clinical Reviews in Allergy & Immunology

28 August 2017

23 October 2022

2 references

28 August 2017

23 October 2022

45

1 reference

28 August 2017

3

1 reference

28 August 2017

331-379

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-013-8368-9

28 August 2017

0 references

cites work

Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Clinical and epidemiologic characteristics of respiratory syncytial virus subgroups A and B infections in Santa Fe, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus genotypes and disease severity among children in hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory Syncytial Virus Infections within Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infections in previously healthy working adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection in adult populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Influenza- and respiratory syncytial virus-associated mortality and hospitalisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Diagnosis and management of bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Detection of respiratory syncytial virus, parainfluenzavirus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk factors for hospitalization with lower respiratory tract infections in children in rural Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Rhinovirus illnesses during infancy predict subsequent childhood wheezing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The burden of respiratory syncytial virus infection in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalization for respiratory syncytial virus in the paediatric population in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of rhinovirus infection with increased disease severity in acute bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Multiple viral respiratory pathogens in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

High rate of viral identification and coinfections in infants with acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Frequency of detection of picornaviruses and seven other respiratory pathogens in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severity of respiratory syncytial virus infection is related to virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk factors for severe respiratory syncytial virus infection among Alaska native children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus load predicts disease severity in previously healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Variation in severity of respiratory syncytial virus infections with subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Molecular epidemiology and disease severity of respiratory syncytial virus in relation to other potential pathogens in children hospitalized with acute respiratory infection in Jordan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Correlation between respiratory syncytial virus genotype and severity of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus: G gene genotype and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus group A and B genotypes and disease severity among Cuban children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Different NF-κB activation characteristics of human respiratory syncytial virus subgroups A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Human bocavirus and other respiratory viral infections in a 2-year cohort of hospitalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prospective study of human metapneumovirus infection in children less than 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Human metapneumovirus in severe respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Epinephrine and dexamethasone in children with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus morbidity and outpatient palivizumab dosing in South Carolina, 2004-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Optimum dosage regimen of palivizumab?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pathogenesis of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Viral and host factors in human respiratory syncytial virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The challenges of vaccine responses in early life: selected examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The histopathology of fatal untreated human respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus and human bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RS virus-induced inflammation and the intracellular glutathione redox state in cultured human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Deletion of CCR1 attenuates pathophysiologic responses during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RSV-infected airway epithelial cells cause biphasic up-regulation of CCR1 expression on human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Animal models of human respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The role of IFN in respiratory syncytial virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein-A enhances respiratory syncytial virus clearance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role for innate IFNs in determining respiratory syncytial virus immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Subversion of pulmonary dendritic cell function by paramyxovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interleukin-13 in asthma pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The role of virus-specific immunoglobulin E in airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunopathogenesis of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Correlation between inflammatory mediators in the nasopharyngeal secretion and in the serum of children with lower respiratory tract infection caused by respiratory syncytial virus and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Activation of the granzyme pathway in children with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Leucocyte populations in respiratory syncytial virus-induced bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pathological changes in virus infections of the lower respiratory tract in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Human metapneumovirus elicits weak IFN-gamma memory responses compared with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Cytokines in severe respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Longitudinal study of intracellular T cell cytokine production in infants compared to adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Relationship between atopic status and nasal interleukin 10 and 11 levels in infants with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increased concordance of severe respiratory syncytial virus infection in identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Neutrophil TLR4 expression is reduced in the airways of infants with severe bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Polymorphisms of toll like receptors in the genetics of severe RSV associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein levels in severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

SP-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in Chilean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Uteroglobulin-related protein 1 and severity of respiratory syncytial virus infection in children admitted to hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunoglobulin heavy G2 chain (IGHG2) gene restriction in the development of severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genomewide association analysis of respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Clara cell protein 10 polymorphism is not associated with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Recurrent wheezing in children with respiratory syncytial virus (RSV) bronchiolitis in Qatar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory status and allergy after bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory status and allergy nine to 10 years after acute bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The outcome after severe bronchiolitis is related to gender and virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunological responses to respiratory syncytial virus infection in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Assessment of IgE response and cytokine gene expression in pulmonary efferent lymph collected after ovalbumin inhalation during experimental infection of calves with bovine respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory morbidity 20 years after RSV infection in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association of an early respiratory syncytial virus infection and atopic allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Latency and persistence of respiratory syncytial virus despite T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory syncytial virus persistence in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Reduced lung function both before bronchiolitis and at 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Lung function prior to viral lower respiratory tract infections in prematurely born infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Group Health Medical Associates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Lung function development in the first 2 yr of life is independent of allergic diseases by 2 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A longitudinal, population-based, cohort study of childhood asthma followed to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Evidence of a causal role of winter virus infection during infancy in early childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Causal links between RSV infection and asthma: no clear answers to an old question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The genetics of asthma and allergic disease: a 21st century perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A role for immune complexes in enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Challenges in developing a pediatric RSV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The effects of respiratory infections, atopy, and breastfeeding on childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Virologically confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and parainfluenza viruses in children in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Viral epidemiology and severity of respiratory infections in infants in 2009: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Detection of IgE antibodies to bovine respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Interaction between Asthma and Lung Function Growth in Early Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Effectiveness of palivizumab prophylaxis in infants and children in Florida

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

NK Cell Deficiency Predisposes to Viral-Induced Th2-Type Allergic Inflammation via Epithelial-Derived IL-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Postnatal Development of Monocyte Cytokine Responses to Bacterial Lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-013-8368-9

Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

21 January 2018

1 reference

12 December 2020

Respiratory syncytial virus vaccine development

1 reference

12 December 2020

Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes

1 reference

12 December 2020

Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice

1 reference

12 December 2020

Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus

1 reference

12 December 2020

Atopy predisposing to acute bronchiolitis during an epidemic of respiratory syncytial virus

1 reference

12 December 2020

Relationship between lower respiratory tract infections caused by respiratory syncytial virus and subsequent development of asthma in Japanese children

1 reference

12 December 2020

Respiratory syncytial viral infection in children with compromised immune function

1 reference

12 December 2020

Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.

1 reference

12 December 2020

The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years

1 reference

12 December 2020

Respiratory syncytial virus infection in anti-mu-treated mice

1 reference

12 December 2020

An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells

1 reference

12 December 2020

Glucocorticoids for acute viral bronchiolitis in infants and young children

1 reference

12 December 2020

Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis

1 reference

12 December 2020

Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing

1 reference

12 December 2020

The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.

1 reference

12 December 2020

Haplotype of IL-8 -251T and 781C is associated with the susceptibility to respiratory syncytial virus

1 reference

12 December 2020

Relationship between RANTES polymorphisms and respiratory syncytial virus bronchiolitis in a Japanese infant population.

1 reference

12 December 2020

Antibiotics for bronchiolitis in children

1 reference

12 December 2020

Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

1 reference

12 December 2020

Polymorphisms of interferons and their receptors in the genetics of severe RSV-associated diseases

1 reference

12 December 2020

Human metapneumovirus infection in young children hospitalized with respiratory tract disease

1 reference

12 December 2020

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

12 December 2020

Epidemiological and clinical features of hMPV, RSV and RVs infections in young children

1 reference

12 December 2020

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

12 December 2020

Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection

1 reference

12 December 2020

Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration

1 reference

12 December 2020

Neonatal adaptive immunity comes of age

1 reference

12 December 2020

A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis

1 reference

12 December 2020

IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis

1 reference

12 December 2020

Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study

1 reference

12 December 2020

Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

1 reference

12 December 2020

Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

1 reference

12 December 2020

Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls

1 reference

12 December 2020

Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation

1 reference

12 December 2020

Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Bronchiolitis in Inuit children from a Canadian central arctic community, 1995-1996.

1 reference

12 December 2020

The Impact of Dual Viral Infection in Infants Admitted to a Pediatric Intensive Care Unit Associated with Severe Bronchiolitis

1 reference

12 December 2020

Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile

1 reference

12 December 2020

Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Effect of variation in RANTES promoter on serum RANTES levels and risk of recurrent wheezing after RSV bronchiolitis in children from Han, Southern China

1 reference

12 December 2020

Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting

1 reference

12 December 2020

Viral etiology in hospitalized children with acute lower respiratory tract infection.

1 reference

12 December 2020

Surfactant therapy for bronchiolitis in critically ill infants

1 reference

12 December 2020

The role of dendritic cells in asthma

1 reference

12 December 2020

Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity

1 reference

12 December 2020

Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study

1 reference

12 December 2020

Reduced neonatal lung function and wheezing illnesses during the first 5 years of life

1 reference

12 December 2020

Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

1 reference

12 December 2020

Incidence of respiratory syncytial virus-positive hospitalizations in Germany.

1 reference

12 December 2020

Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages

1 reference

12 December 2020

Haplotypes of surfactant protein C are associated with common paediatric lung diseases

1 reference

12 December 2020

Cytokine responses correlate differentially with age in infancy and early childhood

1 reference

12 December 2020

Bronchiolitis as a possible cause of wheezing in childhood: new evidence.

1 reference

12 December 2020

IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection

1 reference

12 December 2020

Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children

1 reference

12 December 2020

Hospitalization rates for human metapneumovirus infection among 0- to 3-year-olds in Gipuzkoa (Basque Country), Spain

1 reference

12 December 2020

Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains

1 reference

12 December 2020

Recovery of cytopathogenic agent from chimpanzees with coryza

1 reference

12 December 2020

Respiratory syncytial virus affects pulmonary function in BALB/c mice.

1 reference

12 December 2020

High rates of hospitalisation for bronchiolitis in Inuit children on Baffin Island.

1 reference

12 December 2020

Lung function at 10 yr is not impaired by early childhood lower respiratory tract infections

1 reference

12 December 2020

Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing

1 reference

12 December 2020

Lung function and bronchial hyper-responsiveness 11 years after hospitalization for bronchiolitis

1 reference

12 December 2020

Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy

1 reference

12 December 2020

Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study

1 reference

12 December 2020

Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection

1 reference

12 December 2020

Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection

1 reference

12 December 2020

Family history of atopy and clinical course of RSV infection in ambulatory and hospitalized infants

1 reference

12 December 2020

Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice

1 reference

12 December 2020

Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study

1 reference

12 December 2020

CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness

1 reference

12 December 2020

Determinants of asthma after severe respiratory syncytial virus bronchiolitis

1 reference

12 December 2020

Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children.

1 reference

12 December 2020

10.1007/S12016-013-8368-9

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

0 references

1 reference